CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.
Cleerly's CLARIFY 2 study demonstrates the efficacy of its non-invasive AI-enabled CCTA approach for heart disease evaluation

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Picture of Cleerly Cleerly: February 14, 2022

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation.

new standard of care CCTA-based approach AI-enabled CCTA approach heart attack prevention
Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

Picture of Cleerly Cleerly: February 8, 2022

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...

new standard of care CCTA-based approach AI-enabled CCTA approach heart attack prevention
Read More »
Cleerly envisions a world without heart attacks, keeping families together.

4 min read

Envisioning a World Without Heart Attacks: A Call For A New Paradigm of Precision Heart Care

Picture of James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: January 28, 2022

Historically, our diagnostic approaches to patients with suspected heart disease have been restricted to the evaluation of patients with symptoms...

new standard of care heart attack prevention vision for cardiovascular care
Read More »
Prev 1 2 3 4